Epidemiology: Data from Cancer Registries
Recent advances in the cancer treatment and the resulting increase in patient survival have led to greater scientific interest in multiple primary malignancies (MPM). It is now recognized that longer survival combined with the administration of active but toxic therapeutic regimens has made patients more prone to develop a “second primary cancer,” as a consequence of therapy (e.g., thyroid cancer in lymphoma patients treated with radiotherapy) or of longer exposure to risk factors .
Unable to display preview. Download preview PDF.
- 1.Curtis RE, Freedman M, Ron E et al (eds) (2006) New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000, NCI, Bethesda pp 1–7Google Scholar
- 2.IARC/IACR (2004) International rules for multiple primary cancer. ICD-O, 3rd edn. International Agency for Research on Cancer, Lyon, Internal Report 2004/02Google Scholar
- 4.National Cancer Institutes (2007) SEER program coding and staging manual. Released May 15, 2007. Available at http://seer.cancer.gov/tools/codingmanuals/ (last access July 2008)Google Scholar
- 5.Banca Dati Airtum. Available at www.registri-tumuri.it/cms/?q=bancadati (last access July 2008)Google Scholar
- 6.EUROCARE website. Available at http://www.eurocare.it/Scripts/Document.htm (last access July 2008).Google Scholar
- 7.Rosso S, De Angelis R, Ciccolallo L et al (2008) Survival with multiple tumors. Eur J Cancer (in press)Google Scholar
- 8.National Cancer Institute (2006) About SEER. NIH publication no. 05-4772. Available at http://seer.cancer.gov/about/ (last access July 2008)Google Scholar